IL HB1462 | 2021-2022 | 102nd General Assembly
Status
Spectrum: Partisan Bill (Democrat 29-0)
Status: Introduced on February 11 2021 - 25% progression, died in committee
Action: 2022-09-06 - Added Co-Sponsor Rep. Michael Halpin
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 11 2021 - 25% progression, died in committee
Action: 2022-09-06 - Added Co-Sponsor Rep. Michael Halpin
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Creates the Prescription Drug Affordability Act. Defines terms. Establishes the Prescription Drug Affordability Board and provides that the Board's purpose is to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains other provisions about the Board, including: members of the Board; conflicts of interest; terms of members; the hiring of an executive director, general counsel, and staff for the Board; staff salary; meetings of the Board; and powers and duties of the Board. Creates the Prescription Drug Affordability Stakeholder Council with the purpose to provide stakeholder input to assist the Prescription Drug Affordability Board in making decisions as required under the Act. Contains other provisions about the Council, including: members of the Council; terms of members; and reimbursement of member travel expenses. Provides that the Board shall identify specified prescription drug products and determine whether each prescription drug product should be subject to a cost review. Provides that if the Board finds that spending on a prescription drug product has led or will lead to an affordability challenge, the Board shall establish an upper payment limit after considering: (i) the cost of administering the drug; (ii) the cost of delivering the drug to consumers; and (iii) other relevant administrative costs related to the drug. Includes provisions regarding remedies and an appeal process. Creates the Prescription Drug Affordability Fund to be used only to provide funding for the Board and for the purposes authorized under the Act. Provides that the Board shall submit a report to the General Assembly including specified information. Provides that the Board shall conduct a study of the operation of the generic drug market that includes specified information on or before June 1, 2023. Includes a provision on term expiration for Board and Council members. Makes conforming changes in the State Finance Act. Effective January 1, 2023.
Title
REGULATION-TECH
Sponsors
Roll Calls
2022-04-04 - House - Third Reading in House (Y: 56 N: 0 NV: 54 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-09-06 | House | Added Co-Sponsor Rep. Michael Halpin |
| 2022-04-11 | House | Rule 19(a) / Re-referred to Rules Committee |
| 2022-04-05 | House | Added Co-Sponsor Rep. Delia C. Ramirez |
| 2022-04-05 | House | Added Co-Sponsor Rep. Lindsey LaPointe |
| 2022-04-05 | House | Added Co-Sponsor Rep. Justin Slaughter |
| 2022-04-05 | House | Added Co-Sponsor Rep. Edgar Gonzalez, Jr. |
| 2022-04-05 | House | Added Co-Sponsor Rep. Dagmara Avelar |
| 2022-04-05 | House | Added Co-Sponsor Rep. Sue Scherer |
| 2022-04-05 | House | Added Co-Sponsor Rep. Stephanie A. Kifowit |
| 2022-04-05 | House | Added Co-Sponsor Rep. Joyce Mason |
| 2022-04-05 | House | Added Co-Sponsor Rep. Kelly M. Cassidy |
| 2022-04-05 | House | Added Co-Sponsor Rep. Cyril Nichols |
| 2022-04-05 | House | Added Co-Sponsor Rep. Natalie A. Manley |
| 2022-04-05 | House | Added Co-Sponsor Rep. LaToya Greenwood |
| 2022-04-04 | House | Added Co-Sponsor Rep. Aaron M. Ortiz |
| 2022-04-04 | House | Added Co-Sponsor Rep. Michael J. Zalewski |
| 2022-04-04 | House | Added Co-Sponsor Rep. Jawaharial Williams |
| 2022-04-04 | House | Added Co-Sponsor Rep. Theresa Mah |
| 2022-04-04 | House | Added Co-Sponsor Rep. Robyn Gabel |
| 2022-04-04 | House | Added Co-Sponsor Rep. Bob Morgan |
| 2022-04-04 | House | Added Co-Sponsor Rep. Denyse Wang Stoneback |
| 2022-04-04 | House | Added Co-Sponsor Rep. Kathleen Willis |
| 2022-04-04 | House | Added Co-Sponsor Rep. Michelle Mussman |
| 2022-04-04 | House | Added Co-Sponsor Rep. Debbie Meyers-Martin |
| 2022-04-04 | House | Added Co-Sponsor Rep. Suzanne Ness |
| 2022-04-04 | House | House Floor Amendment No. 1 Adopted 056-000-001 |
| 2022-04-04 | House | Chief Sponsor Changed to Rep. Janet Yang Rohr |
| 2022-04-04 | House | Added Chief Co-Sponsor Rep. Will Guzzardi |
| 2022-04-04 | House | Added Chief Co-Sponsor Rep. Katie Stuart |
| 2022-04-04 | House | Added Chief Co-Sponsor Rep. Maura Hirschauer |
| 2022-04-04 | House | Added Chief Co-Sponsor Rep. Anne Stava-Murray |
| 2022-04-04 | House | House Floor Amendment No. 1 Recommends Be Adopted Rules Committee; 003-002-000 |
| 2022-04-04 | House | House Floor Amendment No. 1 Referred to Rules Committee |
| 2022-04-04 | House | House Floor Amendment No. 1 Filed with Clerk by Rep. Janet Yang Rohr |
| 2022-04-04 | House | Placed on Calendar 2nd Reading - Short Debate |
| 2022-04-04 | House | Approved for Consideration Rules Committee; 003-002-000 |
| 2022-04-04 | House | Final Action Deadline Extended-9(b) April 8, 2022 |
| 2021-04-23 | House | Rule 19(a) / Re-referred to Rules Committee |
| 2021-04-20 | House | Held on Calendar Order of Second Reading - Short Debate ** |
| 2021-04-20 | House | Second Reading - Short Debate |
| 2021-03-17 | House | Placed on Calendar 2nd Reading - Short Debate ** |
| 2021-03-11 | House | Do Pass / Short Debate Executive Committee; 014-000-000 |
| 2021-03-02 | House | Assigned to Executive Committee |
| 2021-02-17 | House | Referred to Rules Committee |
| 2021-02-17 | House | First Reading |
| 2021-02-11 | House | Filed with the Clerk by Rep. Emanuel Chris Welch |
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 215 | 5 | 123D-1 | Amended Code | Citation Text |
